Delivery Order SPE2DB24D3013-SPE2DB25FFMJV
Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,143.87 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (semaglutide), a GLP-1 receptor agonist medication commonly used for weight management and diabetes treatment. The award, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,906.45 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used for weight management. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a $1,525.16 delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by July 16, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under the company's larger pharmaceutical supply relationship with the Defense Logistics...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,954.55 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen (0.5 mL), a semaglutide-based diabetes and weight management medication. This non-set-aside delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,380.95 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract involves...
- The Defense Logistics Agency awarded a delivery order valued at $5,719.35 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pens on September 27, 2025, with completion scheduled for September 29, 2025. This firm fixed price delivery order represents a direct purchase of the FDA-approved diabetes and weight management medication through a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to the place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 ml pen injections, with a ceiling value of $1,143.87 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery...
- The Defense Logistics Agency awarded a $21,963.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pens on May 6, 2025, with an ultimate completion date of May 7, 2025. This contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase of the diabetes and weight management medication under...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pen injections on September 24, 2025, with completion expected by September 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to...